Home|Journals|Articles by Year|Audio Abstracts
 

Research Article



Biosynthesis Of Silver Nanoparticles Using Rose and Jasmine and Its Anti Diabetic Potential

Kaviya Selvaraj, Abirami Arthanari*, S.Rajeshkumar.




Abstract

Introduction: Rose (rosa canina) is one of the flowers that are much in demand by the community because besides being
an ornamental flower it can also be used as a cosmetic. Traditional medicinal herbs have seen a rebound in recent years,
and as a result, pharmaceutical companies are investing heavily in developing natural medications derived from plants.
Aim: To study the Anti-diabetic activity of Rose Jasmine formulation mediated silver nanoparticles.
Materials and methods: The anti-diabetic activity was tested by the following inhibition of α-glucosidase at different
concentrations of the prepared extract mediated with silver nanoparticles.
Result: Using rosa and jasminum extract in the manufacture of silver nanoparticles, the nanoparticles showed remarkable
anti-diabetic activity. It was discovered that the herbal effect was less harmful. Rosa jasminum extract of AgNps showed
good anti-diabetic efficacy in the BSA assays.
Conclusion: Result of this study suggest that biosynthesis of silver nano particle using rose and Jasmine showed its anti
diabetic activity

Key words: Rosa canina, Nanoparticles, Anticariogenic activity,Silver Nanoparticles






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.